Scientists Find New Way to Mobilize Immune System against Viruses

Uncategorized May 13, 2014 at 1:51 PM 0 comments

University of British Columbia scientists have uncovered an intricate chain reaction in the body’s immune system and have used the knowledge to develop a new treatment against harmful viruses. Viral pandemics, such as the coronavirus that caused the deadly SARS outbreak in 2002, have caused hundreds of deaths in Canada,Read More

New Method Sneaks Drugs into Cancer Cells before Triggering Release

Uncategorized May 9, 2014 at 3:49 PM 0 comments

Biomedical engineering researchers have developed an anti-cancer drug delivery method that essentially smuggles the drug into a cancer cell before triggering its release. The method can be likened to keeping a cancer-killing bomb and its detonator separate until they are inside a cancer cell, where they then combine to destroyRead More

Aspirin Can Reduce Colorectal Cancer Risks for Those with Specific Gene

Uncategorized April 24, 2014 at 2:16 PM 0 comments

The humble aspirin may have just added another beneficial effect beyond its ability to ameliorate headaches and reduce the risk of heart attacks: lowering colon cancer risk among people with high levels of a specific type of gene. The extraordinary finding comes from a multi-institutional team that analyzed data andRead More

Enzyme Revealed as Promising Target to Treat Asthma and Cancer

Enzyme Revealed as Promising Target to Treat Asthma and Cancer

Uncategorized April 15, 2014 at 3:23 PM 0 comments

In experiments with mice, Johns Hopkins Kimmel Cancer Center scientists have identified an enzyme involved in the regulation of immune system T cells that could be a useful target in treating asthma and boosting the effects of certain cancer therapies. In research described online April 6 in Nature Immunology, theRead More

Review of Testosterone-Containing Medicines Started

Uncategorized April 11, 2014 at 3:11 PM 0 comments

The European Medicines Agency has started a review of testosterone-containing medicines, mainly used in men who do not produce enough testosterone (a condition known as hypogonadism). The review was triggered by the Estonian medicines agency, the State Agency of Medicines, over concerns about side effects of medicines containing testosterone onRead More

Caffeine against Alzheimer’s Disease

Uncategorized April 8, 2014 at 11:26 AM 0 comments

As part of a German-French research project, a team led by Dr. Christa E. Müller from the University of Bonn and Dr. David Blum from the University of Lille was able to demonstrate for the first time that caffeine has a positive effect on tau deposits in Alzheimer’s disease. TheRead More

Analysis of EUROMAX and HORIZONS-AMI Trials of the Medicines Company’s Angiomax(R) (Bivalirudin) Presented at ACC.14

Uncategorized March 30, 2014 at 3:27 PM 0 comments

New Pooled Analysis of 5,800 Patients Shows Bivalirudin Associated With Reductions in Cardiac Death, Major Bleeding, Transfusion and NACE in STEMI Patients Undergoing PCI; Results Consistent With Previous Results From HORIZONS-AMI and EUROMAX   WASHINGTON, DC, Mar 30, 2014 (Marketwired via COMTEX) — The Medicines Company MDCO -2.86% today reported a presentation ofRead More

Yogurt in Nutrition Initiative Welcomes the Expertise of the International Osteoporosis Foundation as It Highlights the Role of Dairy Products on Bone Health

Uncategorized March 27, 2014 at 11:44 AM 0 comments

The importance of dairy products, including yogurt, to bone health has been recognised again today with the announcement of a new collaboration between the International Osteoporosis Foundation (IOF) and the Yogurt in Nutrition Initiative (YINI). IOF will join forces with the YINI and its current partner, the American Society forRead More

Norgine and Innovacell Dose First Patient in Phase IIb Clinical Trial of ICEF15, a Personalised Cell Therapy to Treat Faecal Incontinence

Uncategorized March 27, 2014 at 11:43 AM 0 comments

Norgine B.V. (“Norgine”) and Innovacell today announced that the first patient has been dosed in the Phase IIb STEFFI study, which has been designed to evaluate the clinical efficacy and safety of ICEF15 (autologous skeletal muscle derived cells), versus placebo in patients suffering from faecal incontinence. The STEFFI study willRead More

‘Early Access’ Scheme Unveiled for Innovative Medicines

‘Early Access’ Scheme Unveiled for Innovative Medicines

Uncategorized March 14, 2014 at 11:34 AM 0 comments

People with advanced cancer and other serious illnesses like dementia could soon benefit from early access to innovative and promising treatments. The Early Access to Medicines scheme would enable safe and promising drugs to be “fast tracked” into the NHS before they have even been granted a licence for use. TheRead More